A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Condition(s) studied
Investigational drug(s) / intervention(s)
eloralintide and tirzepatide: Administered SC
Eloralintide: Administered SC
Tirzepatide: Administered SC
Placebo: Administered SC
Study summary
The purpose of this study is to investigate the efficacy and safety of eloralintide and tirzepatide coformulation (EloraTZP) compared with tirzepatide, eloralintide and placebo for body weight reduction in participants with obesity.
Participation in the study will last about 2 years.
Eligibility
Primary outcome measure(s)
- Percent Change from Baseline in Body Weight — Baseline, Week 100
Trial sites (155)
| Facility | City | Region | Status |
|---|---|---|---|
| Care Access - 801 South Power Road, Mesa | Mesa | Arizona | |
| Headlands Research - Scottsdale | Scottsdale | Arizona | |
| Tucson Clinical Research Institute | Tucson | Arizona | |
| Valley Clinical Trials, Inc. | Covina | California | |
| Los Angeles Institute for Metabolic Research | Los Angeles | California | |
| Peninsula Research Associates | Rolling Hills Estates | California | |
| Artemis Institute for Clinical Research | San Diego | California | |
| Southern California Clinical Research | Santa Ana | California | |
| Yale University School of Medicine | New Haven | Connecticut | |
| JEM Research Institute | Atlantis | Florida | |
| K2 Medical Research - Maitland | Maitland | Florida | |
| Flourish Research - Miami, LLC | Miami | Florida | |
| Care Access - Tamarac | Tamarac | Florida | |
| Care Access - Tampa | Tampa | Florida | |
| Care Access - Dalton Walmart | Dalton | Georgia | |
| Teak Research Consults - Dunwoody | Dunwoody | Georgia | |
| Clinical Research Atlanta | Stockbridge | Georgia | |
| Rophe Adult and Pediatric Medicine/SKYCRNG | Union City | Georgia | |
| East-West Medical Research Institute | Honolulu | Hawaii | |
| IMA Clinical Research Chicago | Chicago | Illinois | |
| DM Clinical Research - Indianapolis | Indianapolis | Indiana | |
| Care Access - Eunice | Eunice | Louisiana | |
| Clinical Trials Management, LLC d/b/a Flourish Research | Metairie | Louisiana | |
| Pharmasite Research, Inc. | Baltimore | Maryland | |
| Care Access - Baltimore | Baltimore | Maryland | |
| Brigham and Women's Hospital Diabetes Program | Boston | Massachusetts | |
| SKY Integrative Medical Center/SKYCRNG | Ridgeland | Mississippi | |
| IMA Clinical Research Las Vegas | Las Vegas | Nevada | |
| Palm Research Center Sunset | Las Vegas | Nevada | |
| IMA Clinical Research Albuquerque | Albuquerque | New Mexico | |
| NYC Research INC | Long Island City | New York | |
| Weill Cornell Medical College | New York | New York | |
| IMA Clinical Research NYC Midtown | New York | New York | |
| University of North Carolina Medical Center | Chapel Hill | North Carolina | |
| Medication Management | Greensboro | North Carolina | |
| Care Access - Raleigh | Raleigh | North Carolina | |
| Clinical Research of Philadelphia | Philadelphia | Pennsylvania | |
| Keystone Clinical Studies | Plymouth Meeting | Pennsylvania | |
| Clinical Neuroscience Solutions Inc. | Memphis | Tennessee | |
| JCCT - Juno Bellaire Site | Bellaire | Texas |
+ 115 more sites — see the full list on the official registry below.
On this site
📄 Mounjaro (tirzepatide) drug profile →More Eli Lilly and Company trials in the UK
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07881432 on ClinicalTrials.gov ↗ ← All trials in the UK